Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
5 evidence topics · 5 sources
SL1009 (sodium dichloroacetate)
Pyruvate dehydrogenase complex deficiency
- Manufacturer
- Saol Therapeutics
- Regulatory submission
- NDA resubmitted June 2026
- Launch
- Not announced
- Last updated